Shehab Mohamed: A Systematic Review on Bleeding as Initial Presentation of CML
Shehab Mohamed, Hematologist at Hamad Medical Corporation, shared on LinkedIn about a recent article by Mohammad ALTermanini et al, published in Clinical and Applied Thrombosis/Hemostasis, adding:
”Continuing our work in myeloid neoplasms and hemostasis
We are proud to share our latest progress in this evolving field.
After previously exploring:
- Bleeding in acute myeloid leukemia (AML)
- Thrombosis in acute promyelocytic leukemia (APL)
- We now expand our work with a new systematic review on bleeding as the initial presentation of chronic myeloid leukemia (CML).
Key findings from our review:
- 53 reported cases identified across the literature
- Strong male predominance (74%)
- Median age: 45 years
Central nervous system bleeding was the most common presentation (40%), followed by:
- Soft tissue hematomas (25%)
- Visceral/splenic bleeding (19%)
- Most patients presented with marked hyperleukocytosis
Despite severity:
- 62% survived
- 21% mortality, mainly due to intracranial hemorrhage or splenic rupture
Key message: Bleeding can be the first manifestation of CML – and should not be overlooked, especially in patients presenting with unexplained hemorrhage and extreme leukocytosis.
This work highlights:
- The complex interplay between malignancy and hemostasis
- The need for early recognition
- The importance of multidisciplinary management
We are excited to keep pushing forward in this field with our team – more to come.”
Title: Review of Bleeding as Initial Presentation in Patients with Chronic Myeloid Leukemia
Authors: Mohammad ALTermanini, Omar Altrmanini, Abdulrhaman F. Al-Mashdali, Ashraf Ahmed, Sara Saeed, Mohamed Fawzi Mudarres, Mohamed Saeed, ElMustafa Abdalla, Dina Soliman, Kalpana Singh, Amin Saied, Motaz Almahmood, Aasir Suliman, Hanaa Qasim, Tareq Abuasab, Fadi Haddad, Mohamed Yassin, Shehab Fareed

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 21, 2026, 15:56Anita Zaidi: Why Only 2% of Health Research and Development Goes to Women’s Conditions
-
Sep 21, 2026, 15:49Omid Khalafi: Gating Strategy and How Do We Decide Which Cells to Analyze
-
Sep 21, 2026, 15:44Levacetylleucine: A New Therapeutic Approach to Ataxia Telangiectasia
-
Sep 21, 2026, 15:40Andreas Tridimas: The Diagnostic Traps of Lipaemic Blood – Why a Normal Amylase Can Mislead You
-
Sep 21, 2026, 15:33Arsene Mekinian: Exploring Cardiac Involvement in Behçet’s Disease
-
Sep 21, 2026, 15:23Anis Mahjoubi: MRI Findings of Krukenberg Tumors
-
Sep 21, 2026, 15:08Fikreab Tesfaye Tefera: 10 Practical Take-Home Points for Diagnosing Iron Deficiency Anemia
-
Sep 21, 2026, 14:10Aswin K Mohan: Lessons from TRANSCON 2026 – Building Resilient Blood Supply Systems Before Crisis Hits
-
Sep 21, 2026, 14:00Vincent Lu: Beyond PT and aPTT – How Hemostasis Evolves Across a Lifetime